Health ❯Healthcare ❯Patient Care

Personalized Medicine

Treatment Options Treatment Strategies Treatment Outcomes Risk Assessment Individualized Treatment Approaches Risk-Adapted Screening Hypothyroidism Management NHS Innovations Symptom Management Adaptive Deep Brain Stimulation

JNK Pathway Loss Drives Resistance to Endocrine and CDK4/6 Treatment in ER+ Breast Cancer

Researchers propose JNK activity testing to help match ER+ patients with the most effective treatments.

CPAP Therapy Reduces Cardiovascular Events in High-Risk OSA Patients but Increases Risk in Low-Risk Group

Biomarker-Enhanced CHA2DS2-VASc Score Personalizes Stroke Prevention in Atrial Fibrillation

Genomic Test Predicts Chemotherapy Resistance in Cancer Patients

Study Urges Geriatric Assessments for Growing Population of Older Breast Cancer Survivors

Chemotherapy-Free Regimen Shows 94% Progression-Free Survival in CLL Trial

Hims & Hers to Acquire Zava, Adding 1.3M Customers in Europe

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

NHS England rolls out world-first liquid biopsy to fast-track cancer treatment

NHS PROGRESS Study Embeds Pharmacogenomics in Primary Care, Alters Treatment for 25% of Patients

New Genomic Score Enhances Prediction of Multiple Myeloma Progression

Study Highlights Patient-Reported Physical Function as Key Predictor of Daratumumab Success in Multiple Myeloma

FDA Approves Adaptive Deep Brain Stimulation for Parkinson’s Treatment

Oxford Study Identifies Most Effective Migraine Treatments

Epilepsy Drug Sulthiame Shows Promise in Treating Sleep Apnea

Adaptive Brain Stimulation Shows Promise in Reducing Parkinson's Symptoms